These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32982961)

  • 21. Lysine-Specific Demethylase 1 Affects the Progression of Papillary Thyroid Carcinoma via HIF1α and microRNA-146a.
    Long M; Zhu Y; Chen Z; Lin S; Peng X; Luo D; Li H; Tan L
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32303750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogenic Ras/squamous cell carcinoma antigen signaling pathway activation promotes invasiveness and lymph node metastases in papillary thyroid carcinoma.
    Luo D; Liu Y; Lin S; Tan L; Du Z; Long M; Zhu Y; Peng X; Zong W; Mackenzie GG; Li H; Ouyang N
    Oncol Rep; 2019 Feb; 41(2):1253-1263. PubMed ID: 30535496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.
    Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S
    Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of ANXA10 inhibits proliferation and promotes apoptosis of papillary thyroid carcinoma cells by down-regulating TSG101 thereby inactivating the MAPK/ERK signaling pathway.
    Wei T; Zhu X
    J Bioenerg Biomembr; 2021 Aug; 53(4):429-440. PubMed ID: 34032966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CircLDLR Promotes Papillary Thyroid Carcinoma Tumorigenicity by Regulating miR-637/LMO4 Axis.
    Jiang YM; Liu W; Jiang L; Chang H
    Dis Markers; 2021; 2021():3977189. PubMed ID: 34925640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of ZNF677 Expression Is an Independent Predictor for Distant Metastasis in Middle Eastern Papillary Thyroid Carcinoma Patients.
    Siraj AK; Poyil PK; Parvathareddy SK; Alobaisi K; Ahmed SO; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of serum lncRNA-ABHD11-AS1 as poor prognosis of patients with papillary thyroid carcinoma.
    Hou S; Zhuang YY; Lin QY; Chen Z; Zhao HG; Zhang L; Lin CH
    Exp Mol Pathol; 2021 Aug; 121():104658. PubMed ID: 34102210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FBXO2 promotes the progression of papillary thyroid carcinoma through the p53 pathway.
    Guo W; Ren Y; Qiu X
    Sci Rep; 2024 Sep; 14(1):22574. PubMed ID: 39343799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
    Wang Y; Liu BG; Zhou CX
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA circBACH2 plays a role in papillary thyroid carcinoma by sponging miR-139-5p and regulating LMO4 expression.
    Cai X; Zhao Z; Dong J; Lv Q; Yun B; Liu J; Shen Y; Kang J; Li J
    Cell Death Dis; 2019 Feb; 10(3):184. PubMed ID: 30796202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-cell and bulk RNA sequencing reveal heterogeneity and diagnostic markers in papillary thyroid carcinoma lymph-node metastasis.
    Lu DN; Zhang WC; Lin YZ; Jiang HY; He R; Li SL; Zhang YN; Shao CY; Zheng CM; Xu JJ; Ge MH
    J Endocrinol Invest; 2024 Jun; 47(6):1513-1530. PubMed ID: 38146045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Semaphorin 3D inhibits proliferation and migration of papillary thyroid carcinoma by regulating MAPK/ERK signaling pathway.
    Hai R; You Q; Wu F; Qiu G; Yang Q; Shu L; Xie L; Zhou X
    Mol Biol Rep; 2022 May; 49(5):3793-3802. PubMed ID: 35190928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA ENST00000539653 acts as an oncogenic factor via MAPK signalling in papillary thyroid cancer.
    Song B; Li R; Zuo Z; Tan J; Liu L; Ding D; Lu Y; Hou D
    BMC Cancer; 2019 Apr; 19(1):297. PubMed ID: 30940124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PDLIM7 Promotes Tumor Metastasis in Papillary Thyroid Carcinoma via Stabilizing Focal Adhesion Kinase Protein.
    Yang F; Yang M; Liu Y; Zhou C; Chen Y; Wu J; Zhang X; Xiao S
    Thyroid; 2024 May; 34(5):598-610. PubMed ID: 38243825
    [No Abstract]   [Full Text] [Related]  

  • 36. IL-34 is a potential biomarker for the treatment of papillary thyroid cancer.
    Zhang P; Zhang H; Dong W; Wang Z; Qin Y; Wu C; Dong Q
    J Clin Lab Anal; 2020 Aug; 34(8):e23335. PubMed ID: 32573824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic targeting of TNIK in papillary thyroid carcinoma: a novel approach for tumor growth suppression.
    Zhang R; Yu Y; Yang Y; Zhang M; Zhang X; Chang Y; Wang S; Hu L; Li J; Zheng X; Zhao R; Guo Y; Ni X
    Med Oncol; 2024 May; 41(6):160. PubMed ID: 38763968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Lin28A/let-7a/c-Myc Pathway in Growth and Malignant Behavior of Papillary Thyroid Carcinoma.
    Huang J; Lin H; Zhong M; Huang J; Sun S; Lin L; Chen Y
    Med Sci Monit; 2018 Dec; 24():8899-8909. PubMed ID: 30531691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solute carrier family 35 member F2 is indispensable for papillary thyroid carcinoma progression through activation of transforming growth factor-β type I receptor/apoptosis signal-regulating kinase 1/mitogen-activated protein kinase signaling axis.
    He J; Jin Y; Zhou M; Li X; Chen W; Wang Y; Gu S; Cao Y; Chu C; Liu X; Zou Q
    Cancer Sci; 2018 Mar; 109(3):642-655. PubMed ID: 29274137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CircPCNXL2 promotes papillary thyroid carcinoma progression by regulating fatty acid metabolism induced by anabolic enzyme ACC1.
    Chu J; Jiang J; Lu X; He G; Zhang D
    Cancer Lett; 2024 Aug; 598():217069. PubMed ID: 38901666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.